Cervical screening: Campaign group 'no further forward'
"No one has taken accountability for the scandal that happened over 13 years and, as a group, we still have many questions that remain unanswered - how did this happen, why did it continue for 13 years and who is going to take responsibility?" the campaign group said.
Expert opinion on reports nearly completed
In December 2024, two reports were published by the Southern Health Trust and PHA following the cervical cytology review.The health committee heard that an expert opinion of these reports, a peer review report by NHS England and several patient learning reviews are nearly completed.They will be published "imminently" in August or September.The Ladies with Letters said in a statement that the delays were "adding to the frustration and disappointment felt by many of the ladies we are in contact with".They said they "cannot understand why a statutory public inquiry has not already been initiated" and that the more they heard today, "the more it seems that the whole cervical screening system is in disarray"."Our firm view is that in order to learn lessons for the future and to restore public confidence in the Cervical Screening Programme in Northern Ireland, we need to establish the full, unvarnished facts of what has happened."This will only happen through a statutory public inquiry which has the power to compel witnesses and evidence from all relevant stakeholders, and more importantly, allow those affected by the scandal to have a voice," they said.
Enda McGarrity, solicitor for the Ladies with Letters said the failures that have occurred have been on an "unprecedented scale".He said the group have engaged with the health minister on these issues for more than a year and they have "waited long enough"."Their request is a simple one - the minister should without further delay establish a statutory public inquiry with full powers to compel evidence, witnesses and which places those who have suffered most at the heart of its work," he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South Wales Argus
34 minutes ago
- South Wales Argus
NHS England approach to doctors' strike ‘seriously risky', BMA warns
British Medical Association (BMA) deputy chairwoman Dr Emma Runswick told BBC Radio 4's Today programme on Tuesday that guidance issued by the health service to keep most planned care running during the walkout could cause dangerous confusion and overstretch staff. 'We've had proven systems over the last decade that have made sure that where we have to take strike action, senior doctors cover urgency and critical care,' she said. 'This time round, NHS England are pushing for the continuation of non-urgent and scheduled care in a way that we think at best is confusing and will create on-the-day cancellations – and at worst could be risky and lead to harm in emergency departments and on wards, because senior doctors cannot physically be in two places at once. 'We think that a notional guidance from NHS England which is saying that basically all scheduled work should continue to go ahead has potential to be seriously risky for patients.' Her comments come amid an escalating row between NHS bosses and the BMA over how hospitals should respond to the strike, which is due to begin at 7am on Friday. During previous rounds of industrial action in 2023 and 2024, NHS England told trusts to cancel large volumes of non-urgent care so that consultants could step in to cover emergency services. But under the leadership of new NHS England chief executive Sir Jim Mackey, hospitals have now been instructed to cancel non-urgent work only in 'exceptional circumstances' – and only with prior approval. The BMA argues this new approach risks spreading non-striking doctors too thinly, with Dr Runswick warning: 'Senior doctors are needed to be freed up in order to provide urgency and critical care. 'We think the vast majority of planned and unscheduled care should be shifted. Health Secretary Wes Streeting has ruled out any additional pay rise (Lucy North/PA) 'There are always, in every hospital, local medical managers, local clinical leaders, who will make decisions about what is safe to go ahead – but trying to maintain scheduled care during this strike is not safe in many cases.' When asked why the union could not avoid strikes altogether, she said walkouts can be delivered safely if planned properly. 'Strikes by doctors do not have to be risky,' she said. 'Strikes by doctors have been run safely in 2016 and 2022, 2023, 2024. 'We are entirely capable of running strikes safely – they just have to be planned for with local medical leadership, and we've done that before. We can do it again.' She said the BMA was still hopeful a resolution could be reached before the walkout begins and was 'keen to work with NHS England to ensure they are best planned for the safest care'. Talks between the Government and the BMA have continued in recent days, with Health Secretary Wes Streeting ruling out any additional pay rise this year but indicating other aspects of the contract – such as student debt, exam fees and working conditions – may be up for negotiation. Resident doctors, formerly known as junior doctors, were awarded an average 5.4% pay increase this financial year, following a 22% rise over the previous two years. However, the BMA says real-terms pay has still fallen by around 20% since 2008, and is pushing for full 'pay restoration'.
Times
7 hours ago
- Times
Doctors to be trained on ME in NHS plan to transform care
Doctors will be trained in dealing with myalgic encephalomyelitis (ME), under a government plan aimed at ensuring there are no more 'tragically avoidable deaths' from the condition. The Department of Health and Social Care has announced that medical students and NHS staff will be offered training modules in how to diagnose, manage and treat ME/chronic fatigue syndrome (CFS). It is part of an ME/CFS delivery plan, aiming to transform care for the illness, commissioned by Sir Sajid Javid, the Conservative health secretary, in 2022. The document, published today, said it was vital the attitudes of NHS staff changed so that patients with ME felt 'heard, believed and not stigmatised'. • ME sufferers 'feel invisible and ignored' amid lottery of NHS care There will also be a public awareness campaign, and schools and social care services will be asked to provide greater support to patients with the condition. The plan outlines steps to improve research and find treatments, including trials to repurpose existing medicines and see if they can help treat ME/CFS. Research teams are being invited to apply for grants of up to £200,000 from the National Institute for Health and Care Research to help find treatments. The health department also said it will explore the provision of a 'specialised service' in the NHS for patients with severe ME, but that this was 'subject to funding availability'. ME is said to affect about 400,000 people in England and Wales with symptoms including exhaustion and pain. Severe cases can be fatal, with patients bedridden and unable to eat or drink. It has taken decades to overturn a misconception that ME is a psychological or behavioural disorder. Ashley Dalton, the public health minister, said the plan was an 'important milestone' to improving care and that people were 'let down' by the health and care system. 'I am painfully aware of patient safety concerns, and even tragically avoidable deaths of people with ME/CFS, in England. These must become never events,' she wrote. However, campaigners said the plan 'is just not good enough', warning that it does not commit to research funding or new NHS services for people with severe ME. • Plan to help ME sufferers has been delayed for too long Inadequate NHS care was highlighted at the inquest of Maeve Boothby O'Neill, who died in 2021 aged 27 from malnutrition caused by severe ME. The coroner issued a prevention of future deaths report calling for attention to 'nonexistent' specialist care. Sonya Chowdhury, chief executive of Action for ME, said: 'We welcome actions included in the plan to redress stigma and improving training of professionals. It's imperative to improve access to health and social care services for people with ME, and this is a good start. We particularly welcome a commitment to explore a specialised service for people with severe and very severe ME. 'However, the plan simply does not go far enough. In particular, we need a funded, dedicated research hub to leverage our world-leading life sciences sector to unlock treatments and ultimately cures for ME. 'Without a commitment to better coordinate research, people with ME will continue to be neglected, overlooked and, for many, confined to their homes. 'The ME community and scientists have been calling for research to be accelerated through a strategic approach for years and we are still not seeing a strategic approach to address this historic shortfall.' Karen Hargrave, from the ThereForME campaign, also called for the plan to be backed by investment. 'This is about more than words on paper: it is about the people lying bedbound in darkened rooms across this country, who desperately need safe NHS care and research to accelerate treatments.' Dr Charles Shepherd, honorary medical adviser to the ME Association, said the group was 'especially disappointed to find that the plan fails to include any real action or funding' to improve treatment of people with ME. He said: 'Around 400,000 people have ME/CFS… this is a major health crisis. So while today's announcement is an important step forward in helping to improve the quality of life of people with ME/CFS, the government must now go much further to improve their medical care and management and help to fund much needed biomedical research into cause and treatment.'
Scotsman
12 hours ago
- Scotsman
UK pharmacists back weight loss jabs - and say it's nothing to be ashamed of
It comes as obesity affects over 1 in 4 adults in the UK | Shutterstock Healthcare professionals are calling for a fundamental shift in public perception around medically supervised weight loss treatments as a quarter of Brits battle obesity. Sign up to our daily newsletter Sign up Thank you for signing up! Did you know with a Digital Subscription to Edinburgh News, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... Happy Pharmacy, an online UK-based pharmacy, is urging the media, healthcare providers, and the public to help dismantle the stigma around prescription weight loss injections. It comes as obesity affects over 1 in 4 adults in the UK - and more people are turning to medically approved treatments to support weight loss under professional supervision. Recent advances in weight loss injections, including Mounjaro® (tirzepatide) and Wegovy® (semaglutide) are shifting perceptions and offering new hope to individuals struggling with weight-related health issues. Palvinder Deol, Superintendent Pharmacist at Happy Pharmacy , said: 'Medications like Mounjaro and Wegovy give people the opportunity to take control of their health in a safe, evidence-based way. 'Obesity is a complex condition involving more than just diet and people deserve support, not judgment, when seeking help.' According to guidance from the National Institute for Health and Care Excellence (NICE) patients with a BMI of 35 or above, or 30+ with weight-related complications, such as high blood pressure or joint problems, may be eligible for these medications as confirmed by NHS England. 'We need to reframe weight loss support as a legitimate medical need,' Palvinder adds. 'When treatments are clinically indicated, patients should feel confident in pursuing them just as they would for any other health condition.' Both medications must be prescribed by a qualified healthcare professional following a full clinical assessment. They are not suitable for everyone, and are only offered to individuals who meet the eligibility criteria outlined by NICE and the MHRA. Following their regulatory approval by the Medicines and Healthcare products Regulatory Agency (MHRA) in late 2023, these treatments are being increasingly prescribed as part of structured weight management programmes across the country. Patients with a BMI of 35 or above, or 30+ with weight-related complications, may be eligible for these medications as confirmed by NHS England | Shutterstock 'We need to reframe weight loss support as a legitimate medical need' Happy Pharmacy, which launched in March 2025, provides a holistic online service offering treatments for weight loss, hair loss, and erectile dysfunction through pharmacist-led consultations. The goal of treatment is not cosmetic enhancement but to reduce long-term risks associated with conditions such as type 2 diabetes, cardiovascular disease, and obstructive sleep apnoea. Despite this clinical backing, Happy Pharmacy reports that many patients hesitate to pursue treatment due to lingering stigma and misinformation about obesity and medical intervention. Despite clinical studies supporting the efficacy of these medications. In a 72-week trial , Mounjaro users lost an average of 20% of their body weight. While participants prescribed Wegovy experienced a 15% reduction in body weight during the same timeframe. Observational data also suggests these treatments may deliver broader health benefits, including lowered risks of stroke and dementia in patients with type 2 diabetes. Beyond health improvements, weight loss injections may also offer economic relief. According to Happy Pharmacy's internal Food Savings Calculator , patients using appetite-suppressing medications could save up to £300 per month on food costs, depending on previous eating patterns. About Happy Pharmacy Happy Pharmacy is a UK-registered and fully regulated online pharmacy with over 10 years of experience in safely dispensing prescription medications nationwide. The service offers convenient access to licensed treatments following consultation with a healthcare professional. Palvinder Deol, BPharm (Hons), is a GPhC‑registered pharmacist with over 25 years of experience. His clinical and educational expertise spans pharmacy practice, weight loss medicines, and patient care. He currently serves as Superintendent Pharmacist ( Happy Pharmacy ).
